Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes

Carcinogenesis

Volumn 18, Issue 4, 1997, Pages 851-854

  Hammons, George J ^a   Milton, Daria ^a   Stepps, Kristy ^a   Guengerich, F Peter ^b   Tukey, Robert H ^c   Kadlubar, Fred F ^a  

^a National Center for Toxicology Research   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 4 BIPHENYLAMINE; AROMATIC AMINE; CYTOCHROME P450; FLUVOXAMINE; FURAFYLLINE; HETEROCYCLIC AMINE; RECOMBINANT ENZYME;

ARTICLE; B LYMPHOBLAST; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HYDROXYLATION; LIVER MICROSOME; METABOLIC ACTIVATION; METABOLISM; PRIORITY JOURNAL;

AMINES; CARCINOGENS; CATALYSIS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYLATION; KINETICS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 0031417971     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.4.851     Document Type: Article

References (48)

1. Guengerich, F.P. (1988) Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48, 2946-2954.
2. Parke, D.V., Ioannides, C. and Lewis, D.F.V. (1991) The role of cytochromes P-450 in the detoxification and activation of drugs and other chemicals. Can. J. Physiol. Pharmacol., 69, 537-549.
3. Nebert, D.W. (1989) The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol., 20, 153-174.
4. Guengerich, F.P. and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391-407.
5. Kadlubar, F.F. (1994) Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyl-transferase and cytochrome P4501A2 phenotyping and genotyping in humans. Drug Metab. Rev., 26, 37-46.
6. Kadlubar, F.F. (1991) Carcinogenic aromatic amine metabolism and DNA adduct detection in humans. In Ernster, L., Esumi, H., Fujii, Y., Gelboin, H.V., Kato, R. and Sugimura, T. (eds), Xenobiotics and Cancer: Implications for Chemical Carcinogenesis and Cancer Chemotherapy. Japan Scientific Press, Tokyo, pp. 339-350.
7. Felton, J.S. and Knize, M.G. (1991) Occurrence, identification and bacterial mutagenicity of heterocyclic amines in cooked food. Mutat. Res., 259, 205-217.
8. Sugimura, T. (1985) Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat. Res., 150, 33-41.
9. Manabe, S., Tohyama, K., Wada, O. and Aramaki, T. (1991) Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis, 12, 1945-1947.
10. Manabe, S., Suzuki, H., Wada, O. and Ueki, A. (1993) Detection of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in beer and wine. Carcinogenesis, 14, 899-901.
11. Ohgaki, H., Takayama, S. and Sugimura, T. (1991) Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res., 259, 399-410.
12. Ito, N., Hasegawa, R., Sano, S., Tamano, S, Esumi, E., Takayama, T. and Sugimura, T. (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5,-b]pyridine (PhIP). Carcinogenesis, 12, 1503-1506.
13. Tanaka, T., Barnes, W.S., Williams, G.M. and Weisburger, J.H. (1985) Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Carcinogenesis, 6, 1043-1048.
14. 1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res., 80, 1176-1178.
15. Adamson, R.H., Thorgeirsson, U.P., Synderwine, E.G., Thorgeirsson, S.S., Reeves, J., Dalgard, D.W., Takayama, S. and Sugimura, T. (1990) Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in non-human primate: induction of tumours in three macaques. Jpn. J. Cancer Res., 81, 10-14.
16. Yamazoe, Y., Abu-Zeid, M., Manabe, S., Toyama, S. and Kato, R. (1988) Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsome and purified cytochrome P450. Carcinogenesis, 9, 105-109.
17. Wallin, H., Mikalsen, A., Guengerich, F.P., Ingelman-Sundberg, M., Solberg, K.E., Rossland, O.J. and Alexander, J. (1990) Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methylphenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis, 11, 489-492.
18. Turteltaub, K.W., Knize, M.G., Buonarati, M.H., McManus, M.E., Veronese, M.E., Mazrimas, J.A. and Felton, J.S. (1990) Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by liver microsomes and isolated rabbit cytochrome P450 isozymes. Carcinogenesis, 11, 941-946.
19. 3_450 of carcinogenic arylamines found in foods. J. Natl. Cancer Inst., 81, 223-227.
20. Frandsen, H., Rasmussen, E.S., Nielsen, P.A., Farmer, P., Dragsted, L. and Larsen, J.C. (1990) Metabolic formation, synthesis and genotoxicity of the N-hydroxy derivative of the food mutagen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP). Mutagenesis, 6, 93-98.
21. Edwards, R.J., Murray, B.P., Murray, S., Schulz, T., Neubert, D., Gant, T.W., Thorgeirsson, S.S., Boobis, A.R. and Davies, D.S. (1994) Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis, 15, 829-836.
22. Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H. and Kadlubar, F.F. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
23. McManus, M.E., Burgess, W.M., Veronese, M.E., Huggett, A., Quattrochi, L.C. and Tukey, R.H. (1990) Metabolism of 2-acetyl-aminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res., 50, 3367-3376.
24. Shimada, T. and Guengerich, F.P. (1991) Activation of amino-α-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res., 51, 5284-5291.
25. Murray, B.P. Edwards, R.J., Murray, S., Singleton, A.M., Davies, D.S. and Boobis, A.R. (1993) Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis, 14, 585-592.
26. Zhao, K., Murray, S., Davies, D.S., Boobis, A.R. and Gooderham, N.J. (1994) Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes. Carcinogenesis, 15, 1285-1288.
27. Shimada, T., Gillam, E.M.J., Sandhu, P., Guo, Z., Tukey, R.H. and Guengerich, F.P. (1994) Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays. Carcinogenesis, 15, 2523-2529.
28. Aoyama, T., Gonzalez, F.J. and Gelboin, H.V. (1989) Human cDNA-expressed cytochrome P450 1A2: mutagen activation and substrate specificity. Mol. Carcinogenesis, 2, 192-198.
29. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl Acad. Sci. USA, 86, 7696-7700.
30. Guo, Z., Gillam, E.M.J., Ohmori, S., Tukey, R.H. and Guengerich, F.P. (1994) Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5′ substitution, stabilization, purified, spectral characterization and catalytic properties. Arch. Biochem. Biophys., 312, 436-446.
31. Sandhu, P., Guo, Z., Baba, T., Martin, M.V., Tukey, R.H., and Guengerich, F.P. (1994) Expression of modified human cytochrome P450 1A2 in Escherichia coli: purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys., 309, 168-177.
32. Gillam, E.M.J., Baba, T., Kim, B.-R., Ohmuri, S. and Guengench, F.P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys., 305, 123-131.
33. 1 by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol., 8, 218-225.
34. Yasukochi, Y. and Masters, B.S.S. (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem., 251, 5337-5344.
35. Shimada, T., Misono, K.S. and Guengerich, F.P. (1986) Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem., 261, 909-921.
36. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378.
37. Lin, D.-X., Lang, N. and Kadlubar, F.F. (1995) Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rat, and mice. Drug Metab. Dispos., 23, 518-524.
38. McKinnon, R.A., Burgess, W.M., Hall, P.M., Zaiminuddin, A.-A. and McManus, M.E. (1992) Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. Cancer Res. (Suppl.), 52, 2108s-2113s.
39. Guengerich, F.P. (1990) Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol., 3, 363-371.
40. Aoyama, T., Gelboin, H.V. and Gonzalez, F.J. (1990) Mutagenic activation of 2-amino-3-methylimidazo[4,5,f]quinoline by complemenary DNA-expressed human liver P-450. Cancer Res., 50, 2060-2063.
41. Sesardic, D., Boobis, A.R., Murray, S., Segura, J., De La Torre, R. and Davies, D.S. (1990) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br. J. Clin. Pharmacol., 29, 651-663.
42. Brosen, K., Skjelbo, E., Rasmussen, B.B., Poulsen, H.E. and Loft, S. (1993) Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem. Pharmacol., 45, 1211-1214.
43. Bourrie, M., Meunier, V., Berger, Y. and Fabre, G. (1996) Cytochrome P450 isoform inhibitors as tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J. Pharmacol. Exper. Ther., 277, 321-332.
44. Tassaneeyakul, W., Birkett, D.J., Veronese, M.E., McManus, M.E., Tukey, R.H. and Miners, J.O. (1994) Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. Pharmacogenetics, 4, 281-284.
45. Kunze, K.L. and Trager, W.F. (1993) Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem. Res. Toxicol., 6, 649-656.
46. Clarke, S.E., Ayrton, A.D. and Chenery, R.J. (1994) Characterization of the inhibition of P4501A2 by furafylline. Xenobiotica, 24, 517-526.
47. Jensen, K.G., Poulsen, H.E., Doehmer, J. and Loft, S. (1995) Kinetics and inhibition by fluvoxamine of phenacetin O-deethylation in V79 cells expressing human CYP1A2. Pharmacol. Toxicol., 76, 286-288.
48. Rich, K.J., Murray, B.P., Lewis, I., Rendell, N.B., Davies, D.S., Gooderham, N.J. and Boobis, A.R. (1992) N-Hydroxy-MeIQx is the major micosomal oxidation produce of the dietary carcinogen MeIQx with human liver. Carcinogenesis, 13, 2221-2226.